When treated with CMs for 24 h, CAF-CM enhanced the expression and activation of NF-κB, whereas Cur-CM and AMD-CM significantly inhibited the NF-κB signaling pathway (Figure 5C). The gene discussed is NFKB1; the disease is age-related macular degeneration.